Gastrobiotic 200 Mg 30 Tablets

Gastrobiotic 200 Mg 30 Tablets

Description:

Gastrobiotic 200 mg 30 tablets is a prescription oral antibiotic medicine containing rifaximin, designed for targeted treatment of certain gastrointestinal infections. It acts locally in the intestine with minimal systemic absorption, making it suitable for managing traveler’s diarrhea caused by noninvasive strains of Escherichia coli in patients over 12 years of age. Rifaximin is also recognized as an adjunctive treatment in hepatic encephalopathy to help reduce blood ammonia levels and improve neurological symptoms. This product is intended for short-term therapeutic use under medical supervision to support digestive health and control infection-related diarrhea.

Indications:

• Treatment of traveler’s diarrhea caused by noninvasive strains of Escherichia coli in patients older than 12 years.
• Adjunctive therapy in hepatic encephalopathy to reduce blood ammonia concentrations and decrease the severity of neurological manifestations (such as confusion, disorientation, and altered mental status), as prescribed by a specialist.
• Helps control acute infectious diarrhea symptoms such as frequent loose stools, abdominal discomfort, and urgency when caused by susceptible organisms, as directed by a physician.

Active Ingredients / Key Components:

• Rifaximin – 200 mg per film-coated tablet.
• Excipients (inactive ingredients) include standard tablet-forming agents (such as fillers, binders, coating materials, and colorants); exact excipient composition and concentrations , please check the product leaflet or the manufacturer’s official website. Please refer to the official package leaflet for the full list of excipients.

Dosage & Administration / How to Use:

• For traveler’s diarrhea (adults and adolescents >12 years): The commonly used dose of rifaximin 200 mg in clinical practice is 200 mg three times daily for 3 days; however, the exact dose, frequency, and duration must be determined by your doctor according to current guidelines and your condition.
• For hepatic encephalopathy (adjunctive therapy): Dosing regimens differ and are individualized by the treating physician. Do not use for this indication without explicit medical supervision.
• Tablets should be swallowed whole with a glass of water. Do not crush or chew unless your doctor or pharmacist advises otherwise.
• Can be taken with or without food, but try to take doses at evenly spaced intervals each day.
• Always complete the full course prescribed, even if symptoms improve earlier, to help prevent recurrence and resistance.
• If you miss a dose, take it as soon as you remember unless it is almost time for the next dose. Do not double the dose to make up for a missed one.
• Use only under medical supervision. Do not self-medicate or share this medicine with others.

Clinical Benefits:

• Targets gastrointestinal infections locally in the gut with minimal systemic absorption, reducing the risk of systemic side effects compared with some other antibiotics.
• Effectively treats traveler’s diarrhea caused by noninvasive strains of Escherichia coli, helping to reduce stool frequency and improve stool consistency.
• Helps improve quality of life in patients with hepatic encephalopathy when used as adjunctive therapy by lowering blood ammonia levels and reducing neurological symptoms.
• Supports faster recovery from infection-related diarrhea, helping restore normal daily activities and travel plans.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity or allergy to rifaximin, other rifamycin derivatives (such as rifampicin, rifabutin), or any of the excipients in the formulation.
• Not recommended for use in diarrhea complicated by fever, blood in stool, or suspected invasive bacterial infections unless specifically directed by a physician.
• Use with caution in patients with severe liver impairment; dosage adjustment or close monitoring may be required as advised by a specialist.
• If symptoms of diarrhea worsen, persist beyond the recommended treatment duration, or are accompanied by signs of severe illness (fever, dehydration, blood or mucus in stools), seek medical attention immediately.
• Prolonged or repeated use may lead to overgrowth of non-susceptible organisms, including Clostridioides difficile; consult your doctor if new or persistent diarrhea occurs after treatment.
• Consult your doctor before use if you are pregnant, planning pregnancy, or breastfeeding. Rifaximin should be used in pregnancy or lactation only if clearly needed and prescribed.
• Inform your doctor about all other medicines you are taking, including over-the-counter drugs and supplements, to avoid potential interactions.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision.
• Keep out of reach of children.

Side Effects:

• Common side effects may include nausea, abdominal pain or cramps, flatulence, headache, and increased defecation. These are usually mild and transient.
• Less common side effects can include vomiting, fever, dizziness, or fatigue.
• Allergic reactions such as rash, itching, swelling (especially of the face, lips, or tongue), or difficulty breathing are rare but serious; stop the medicine and seek emergency medical attention if they occur.
• Severe or persistent diarrhea, especially if watery or bloody, may indicate a more serious condition (including possible C. difficile–associated diarrhea); contact your doctor immediately.
• If you experience any unusual or bothersome symptoms not listed here, consult your healthcare provider.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date printed on the pack. Store at or below the temperature specified on the original packaging insert (exact storage temperature is not available in the provided information; refer to the product box or leaflet).

Specifications:

• Strength: 200 mg rifaximin per film-coated tablet.
• Form: Film-coated tablets for oral use.
• Pack size: 30 tablets per pack.
• Intended use: Prescription-only gastrointestinal antibiotic for traveler’s diarrhea and adjunctive therapy in hepatic encephalopathy, as directed by a physician.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.